Cullinan Oncology, Inc. (CGEM) Financials

CGEM Assets vs Liabilities

DateAssetsLiabilities
2023-12-31 485.1 million 31.2 million
2023-09-30 494.7 million 25.9 million
2023-06-30 522.0 million 22.4 million
2023-03-31 515.0 million 29.3 million

CGEM Free Cash Flow and Stock based compensation

Graph available only for supporters. Become a supporter to see it.
DateFree Cash FlowStock based compensation
2023-12-31 -18.1 million 7.5 million
2023-09-30 -34.1 million 7.7 million
2023-06-30 -31.1 million 7.9 million
2023-03-31 -51.2 million 7.3 million

CGEM Net Income

No data available :(

CGEM Cash and Debt

Graph available only for supporters. Become a supporter to see it.
DateCashDebtCapital Lease
2023-12-31 467.1 million - 3.6 million
2023-09-30 466.4 million - 4.0 million
2023-06-30 512.1 million - 4.4 million
2023-03-31 390.7 million - 4.7 million

CGEM Shares Outstanding

Graph available only for supporters. Become a supporter to see it.
DateShares Outstanding
2023-12-31 42.8 million
2023-09-30 42.7 million
2023-06-30 40.0 million
2023-03-31 40.7 million

CGEM Expenses

Graph available only for supporters. Become a supporter to see it.
DateCapexR&DG&AS&M
2023-12-31 - 34.8 million 10.6 million 77000
2023-09-30 - 33.8 million 11.0 million -
2023-06-30 49000 27.4 million 10.2 million -
2023-03-31 159000 52.1 million 10.7 million -

CGEM Cost of Revenue

Graph available only for supporters. Become a supporter to see it.
DateRevenueCost of Revenue
2023-12-31 - 77000
2023-09-30 - 80000
2023-06-30 - 81000
2023-03-31 - 72000

CGEM

Price: $27.58

52 week price:
7.64
28.10

Earnings Per Share: -3.69 USD

P/E Ratio: -4.79

Exchange: NMS

Sector: Healthcare

Industry: Biotechnology

Volume: 351200

Market Capitalization: 733.0 million

Links: